← Every company
Theravance Biopharma Inc Planned Sales
Before an insider at Theravance Biopharma Inc can sell restricted stock they have to file notice of it. This is that notice — the leading edge of the insider trading feed, filed days before the sale it describes.
TBPH insider trades →Notices on file
1
Insiders
1
Shares noticed
13.3K
permission to sell, not sales
Estimated value
$226.8K
as estimated on filing
Largest notices first
Value is the filer's own estimate of what the sale would raise, at the time they filed.
| Seller | Est. value |
|---|---|
| Farnum RhondaOfficer2026-09-1513.3K sh0.03% | $226.8K |
Source: SEC Form 144 notices, via EDGAR. A notice is permission to sell, not a completed sale — it is often used only in part, or not at all, so none of this is volume and none of it should be added to the insider trading feed. Value is the filer's estimate on the day they filed.
More on TBPH
Company overviewEverything on TBPH in one place, with the price.SEC filingsWhat TBPH's 8-Ks say happened: results, departures, auditor changes.Insider tradingWhat TBPH's own officers and directors buy and sell.Executive payWhat TBPH awarded its chief executive, and what it became.PatentsWhat TBPH is filing at the patent office.